Use of thermo-coagulation as an alternative treatment modality in a ‘screen-and-treat’ programme of cervical screening in rural Malawi

International Journal of Cancer

Volumn 139, Issue 4, 2016, Pages 908-915

  Campbell, Christine ^a   Kafwafwa, Savel ^b   Brown, Hilary ^c   Walker, Graeme ^c   Madetsa, Belito ^b   Deeny, Miriam ^d   Kabota, Beatrice ^b   Morton, David ^b   Ter Haar, Reynier ^b   Grant, Liz ^e   Cubie, Heather A ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Social Dimensions of Health Institute   (Malawi)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d STOBHILL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ablative treatment; cervical screening; thermo coagulation; VIA; screen and treat

Indexed keywords

ACETIC ACID;

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SCREENING; COMPETENCE; CONTROLLED STUDY; CRYOTHERAPY; FEASIBILITY STUDY; FEMALE; GAS; HEALTH CARE; HEALTH CENTER; HEALTH SERVICE; HOSPITAL CARE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALAWI; PRIORITY JOURNAL; PUNCH BIOPSY; QUALITY CONTROL; RURAL AREA; THERMOCOAGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84976568053     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30101     Document Type: Article

References (41)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, Accessed on April 24, 2016.
2. Arbyn M, Castellsagué X, de Sanjosé S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22:2675–86.
3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2014. Available from: http://globocan.iarc.fr. Accessed on January 16, 2015.
4. Kohler RE, Tang J, Gopal S, et al. High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi. Int J STD AIDS, 2015 Jun 30. pii: 0956462415592999. [Epub ahead of print]
5. The Malawi Health Sector Strategic Plan (HSSP), 2011−2016. Available from: http://www.medcol.mw/commhealth/publications/3%20Malawi%20HSSP%20Final%20Document%20(3).pdf. Accessed on October 7, 2015.
6. World Health Organisation. Comprehensive cervical cancer control: a guide to essential practice (C4-GEP). Geneva, Switzerland: Department of Reproductive Health and Research and Development of Chronic Diseases and Health Promotion, World Health Organisation, 2006.
7. World Health Organisation. Comprehensive cervical cancer control: a guide to essential practice, 2nd edn. 2014. Available from: http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf. Accessed on November 9, 2015.
8. Treatment technologies for precancerous cervical lesions in low-resource settings: review and evaluation. PATH, 2013. Available from: www.rho.org/HPV-screening-treatment.htm. Accessed on April 21, 2016.
9. Gordon HK, Duncan ID. Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100°C using the Semm cold coagulator: 14 years' experience. Br J Obstet Gynaecol 1991;98:14–20.
10. Parry-Smith W, Underwood MD, Bellis-Ayres S, et al. Success rate of thermo-coagulation for the treatment of cervical intraepithelial neoplasia: a retrospective analysis of a series of cases. J Low Genit Tract Dis 2015;19:17–21.
11. Coupar E, McKenzie C. Results of Test of Cure (ToC) in patients undergoing treatment with cold coagulation and large loop excision of transformation zone (LLETZ). Paper presented at the British Gynaecological Cancer Society Annual Scientific Meeting, July 10–11, 2014, London, UK.
12. Dolman L, Sauvaget C, Muwonge R, et al. Meta-analysis of the efficacy of thermo-coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review. BJOG 2014;121:929–42.
13. Joshi S, Sankaranarayanan R, Muwonge R, et al. Screening of cervical neoplasia in HIV-infected women in India. AIDS 2013;27:607–15.
14. Joshi S, Kulkarni V, Darak T, et al. Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using “screen and treat” approach. Int J Womens Health 2015;7:477–83.
15. Nene BM, Hiremath PS, Kane S, et al. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet 2008;103:232–6.
16. Nkhoma Hospital website. Available from: http://nkhomahospital.org.mw. Accessed on July 20, 2015.
17. Vink NM, de Jonge HC, Ter Haar R, et al. Maternal death reviews at a rural hospital in Malawi. Int J Gynaecol Obstet 2013;120:74–7.
18. Blumenthal PD, McIntosh N. Cervical Cancer Prevention Guidelines for Low-Resource Settings. Jhpiego 2005. http://reprolineplus.org/system/files/resources/CeCaPfullmanual.pdf. Accessed on April 21, 2016.
19. World Health Organization. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. Geneva, Switzerland: World Health Organization, 2012.
20. Ramogola-Masire D, de Klerk R, Monare B, et al. Cervical cancer prevention in HIV-infected women using the “screen and treat” approach in Botswana. J Acquir Immune Defic Syndr 2012;59:308–13.
21. Kapambwe S, Sahasrabuddhe VV, Blevins M, et al. Implementation and operational research: age distribution and determinants of invasive cervical cancer in a “screen-and-treat” program integrated with HIV/AIDS care in Zambia. J Acquir Immune Defic Syndr 2015;70:e20–6.
22. Khozaim K, Orang'o E, Christoffersen-Deb A, et al. Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya. Int J Gynaecol Obstet 2014;124:12–8.
23. Phiri S, Feldacker C, Chaweza T, et al.; Lighthouse Group. Integrating reproductive health services into HIV care: strategies for successful implementation in a low-resource HIV clinic in Lilongwe, Malawi. J Fam Plann Reprod Health Care 2016;42:17–23.
24. Sauvaget C, Muwonge R, Sankaranarayanan R. Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2013;120:218–23.
25. Fort VK, Makin MS, Siegler AJ, et al. Barriers to cervical cancer screening in Mulanje, Malawi: a qualitative study. Patient Prefer Adherence 2011;5:125–31.
26. Maseko FC, Chirwa ML, Muula AS. Health systems challenges in cervical cancer prevention program in Malawi. Glob Health Action 2015;8:26282.
27. Munthali AC, Ngwira BM, Taulo F. Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providers. Patient Prefer Adherence 2015;9:501–8.
28. Maseko FC, Chirwa ML, Muula AS. Client satisfaction with cervical cancer screening in Malawi. BMC Health Serv Res 2014;14:420.
29. Ferreccio C, Gage J. Visual Inspection of the Uterine Cervix with Acetic Acid (VIA): A Critical Review and Selected Articles. Washington, D.C.: PAHO, 2003. http://www1.paho.org/hq/dmdocuments/2011/cc-via.pdf. Accessed on April 21, 2016.
30. Goodman JD, Sumner D. Patient acceptability of laser and thermo-coagulation therapy for pre-malignant disease of the uterine cervix. Br J Obstet Gynaecol 1991;98:1168–71.
31. Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health 2014;80:412–7.
32. Bateman AC, Katundu K, Mwanahamuntu MH, et al. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer 2015;15:541.
33. Soutter WP, de Barros Lopes A, Fletcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978–80.
34. WISAP. Available from: http://www.wisap.de. Accessed on November 9, 2015.
35. Tsu V, Jeronimo J. Are alternatives to traditional cryotherapy needed? What options exist? Paper presented at the HPV Conference, Lisbon, September 2015.
36. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, et al. Monitoring the performance of “screen-and-treat” cervical cancer prevention programs. Int J Gynaecol Obstet 2014;126:88–9.
37. World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2014. Available from: http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf. Accessed on June 30, 2015.
38. Basu P, Mittal S, Banerjee D, et al. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India. Int J Cancer 2015;137:859–67.
39. Reddy D, Njala J, Stocker P, et al. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study. Int J STD AIDS 2015;26:379–87.
40. Peters DH, Adam T, Alonge O, et al. Implementation research: what it is and how to do it. BMJ 2013;347:f6753.
41. Denny L. Control of cancer of the cervix in low- and middle-income countries. Ann Surg Oncol 2015;22:728–33.